| Financial Year |
March 31 2023 |
| Monetary Funds |
2,675,633,779.97 |
| Held-for-trading Financial Assets |
45,099,603.60 |
| Notes Receivable |
-- |
| Accounts Receivable |
11,499,554.46 |
| Advances to Suppliers |
42,355,758.63 |
| Other Receivables |
189,218,124.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
16,405,601,055.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
367,167,218.79 |
| Total Current Assets |
19,765,233,333.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
658,352,778.03 |
| Investment Properties |
842,427,520.96 |
| Fixed Assetes |
19,460,226.76 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
991,346.36 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
15,046,601.98 |
| Deferred Income Tax Assets |
568,131,360.75 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,977,170,015.52 |
| Total Assets |
22,742,403,349.30 |
| Short-Term Loans |
350,377,777.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
793,769,475.65 |
| Accounts Received In Advance |
10,334,430.52 |
| Employee Compensation Payable |
16,870,649.78 |
| Taxes Payable |
155,451,171.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,242,613,032.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,446,472,349.82 |
| Other Current Liabilities |
448,806,112.78 |
| Sub-Total of Current Liabilities |
10,599,915,856.48 |
| Long-term Loans |
3,670,789,400.61 |
| Bonds Payable |
3,732,111,037.05 |
| Long-Term Accounts Payable |
296,286.45 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,890,120.06 |
| Other Non-Current Liabilities |
4,223,647.91 |
| Sub-Total of Non-Current Liabilities |
7,476,904,848.95 |
| Total Liabilities |
18,076,820,705.43 |
| Paid-In Capital(Or Share Stock) |
1,050,000,000.00 |
| Capital Surplus |
1,062,183,495.09 |
| Surplus Reserve |
415,436,606.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,978,285,842.74 |
| Minority Stockholder's Interest |
180,659,042.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,484,923,601.82 |
| Owner's Equity（Stockholder's Equity） |
4,665,582,643.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,742,403,349.30 |
